Notable Doping Cases in Powerlifting

Powerlifting is a sport where the result is measured in kilograms on the bar, and the link between anabolic drugs and strength is direct and well studied. It is no surprise that strength disciplines have for decades remained under heightened attention from anti-doping organizations. The editorial team examines the most illustrative cases and the scenarios that recur year after year, and explains what they teach athletes.

Strength sports and doping: historical context

Anabolic steroids came into sport in the 1950s–1960s, and strength disciplines — weightlifting, throwing events, later powerlifting — were among the first to feel their influence. The International Olympic Committee introduced testing for anabolic steroids only in the 1970s, when the drugs had already become entrenched in training culture.

The most documented historical example is the state doping program of the GDR. After the reunification of Germany, biologist Werner Franke and former athlete Brigitte Berendonk released archival documents and in 1997 published an analysis in the journal Clinical Chemistry. It showed the systematic use of androgens, in particular oral Turinabol, in many sports, including strength sports, as well as serious health consequences for athletes, especially women.

Another well-known episode is the 1983 Pan American Games in Caracas, where the introduction of new, more sensitive analysis methods led to a series of positive tests among weightlifters, and some athletes left the competition before the start. This case is often cited as an example of how the improvement of laboratory methods changes athletes' behavior.

Powerlifting as a separate sport took shape later, in the 1970s. The International Powerlifting Federation (IPF) over time became a signatory of the World Anti-Doping Code and conducts testing under its rules. In parallel there are numerous federations without testing or with limited control, which creates a kind of 'dual reality' in the sport.

The Finnish study: the cost to health

One of the most cited works on the consequences of doping in strength sports is the study by Pärssinen and colleagues, published in the International Journal of Sports Medicine in 2000. The authors traced the fate of 62 Finnish powerlifters who placed highly at national competitions in 1977–1982 and, in the researchers' assessment, had probably used anabolic agents.

Over 12 years of observation, mortality in the powerlifters group was 12.9% versus 3.1% in the control group of men from the general population. Among the causes of death were suicides, myocardial infarction, hepatic coma and non-Hodgkin lymphoma. The authors cautiously noted that the study design does not allow a causal link to be proven, but the difference was statistically significant.

These results are consistent with later data. The scientific statement of the Endocrine Society (Pope et al., 2014) systematized the cardiovascular, endocrine and psychiatric consequences of long-term androgen use. Cardiomyopathy, accelerated atherosclerosis and persistent suppression of one's own testosterone synthesis are described as typical for long-term users.

For powerlifting these data are especially important, because in this sport athletes compete for a long time — often up to age 40–50 and beyond in veteran categories. Accordingly, the possible duration of drug use is greater than in sports with a short career.

New detection methods and 'old' samples

A significant part of the well-known cases in strength sports over the last fifteen years is related not to new drugs but to new analysis methods. In 2012 Sobolevsky and Rodchenkov described long-lived metabolites of dehydrochloromethyltestosterone (Turinabol), which can be detected much longer than previous markers. Similar approaches were later developed for stanozolol, methandienone and other oral steroids.

Thanks to such methods, the International Olympic Committee in 2016–2017 re-analyzed samples from the 2008 and 2012 Olympic Games. Weightlifting turned out to be among the sports with the largest number of detected violations, and dozens of medals were redistributed. Although powerlifting is not an Olympic sport, these events became a signal for all strength disciplines.

For powerlifters this means that even old results are not 'closed'. The ten-year statute of limitations allows records and titles to be reviewed if new scientific possibilities appear.

At the same time, improved methods have also raised the requirements for caution among honest athletes. When laboratories detect microquantities, a contaminated supplement or drug becomes a real threat to a career.

Typical case scenarios in powerlifting

An analysis of public decisions by anti-doping organizations shows that cases in powerlifting usually fit into a few recurring scenarios. The editorial team deliberately does not discuss individual athletes whose decisions may be appealed, but describes general patterns.

• Classic anabolic steroids— the most common category; often oral drugs detected by long-lived metabolites.
• Diuretics— used for 'cutting' weight before the weigh-in in a weight category; banned at all times.
• Stimulants— in the competition period, often through pre-workout complexes with an opaque composition.
• SARMs and 'research' substances— often bought as 'legal alternatives', but they belong to class S1.
• Refusal to be tested— is equated with a positive result and entails the same sanction.
• Whereabouts violations— for top-level athletes included in the registered testing pool.

A separate scenario is veterans and amateurs who believe that testing is impossible at their level. In tested federations this is not so: doping control is conducted both at national championships and among veterans, and the sanctions are the same for everyone.

The situation with medications also recurs. Athletes who receive, for example, testosterone by medical prescription sometimes do not obtain a therapeutic use exemption. A prescription does not protect against a case, and such an instance is treated as a full-fledged violation, although medical documents may influence the assessment of fault.

Lessons for athletes and coaches

The first lesson: check the rules of your federation. If you compete in a structure with testing under the WADA Code, the principle of strict liability applies to you — any prohibited substance in a sample is a violation regardless of how it got there.

The second lesson: pre-workout complexes, 'testosterone boosters' and weight-loss supplements are the riskiest category of food supplements. Choose products with independent certification for the absence of prohibited substances and keep receipts and packaging.

The third lesson: diuretics for cutting weight are not only an anti-doping violation but also a direct threat to health. Electrolyte disturbances can cause arrhythmia. It is better to change weight category than to risk your heart.

The fourth lesson concerns coaches. The Code directly provides for liability of support personnel for the distribution, administration of prohibited substances or complicity. A coach who 'advises a cycle' risks a long disqualification and their own reputation.

Editorial conclusions

The history of strength sports is a history of a constant race between pharmacology and control methods. From the GDR to the re-analysis of Olympic samples, laboratories gradually closed off the opportunities for covert drug use.

The most important scientific lesson is given by the Finnish study of powerlifter mortality: the cost of doping is measured not only in disqualifications but also in years of life.

For the modern powerlifter the key risks are long-lived metabolites, contaminated supplements, diuretics before the weigh-in and medications without a therapeutic use exemption.

We also recommend reading our articles on doping in bodybuilding and bikini fitness, on prohibited supplements and on the therapeutic use exemption.

References

1. Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppälä T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000;21(3):225–227.
2. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem. 1997;43(7):1262–1279.
3. Sobolevsky T, Rodchenkov G. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J Steroid Biochem Mol Biol. 2012;128(3–5):121–127.
4. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
5. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem. 1996;42(7):1001–1020.
6. World Anti-Doping Agency. World Anti-Doping Code 2021. Montreal: WADA; 2021.
7. World Anti-Doping Agency. The Prohibited List. Montreal: WADA; чинна редакція.